PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple myeloma |
| Symptom | C0040053|thrombosis |
| Sentences | 9 |
| PubMedID- 22511493 | There was an increase in risk of death among multiple myeloma patients with arterial thrombosis, with hazard ratios of 3.4 (95% ci: 3.0-3.8), 2.2 (95% ci: 2.0-2.3), and 2.1 (95% ci: 1.9-2.1), respectively. |
| PubMedID- 22682142 | Risk and management of thrombosis in multiple myeloma. |
| PubMedID- 20299513 | Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. |
| PubMedID- 25840743 | Background: thalidomide (thal) treatment of patients with multiple myeloma (mm) is associated with vascular thrombosis, but the underlying mechanism is unknown. |
| PubMedID- 20952063 | The impact of bortezomib on the risk of thrombosis in multiple myeloma. |
| PubMedID- 23514991 | This review will cover potential risk factors for thrombosis in patients with multiple myeloma, prevention recommendations and treatment strategies in this clinical setting. |
| PubMedID- 21239832 | thrombosis in multiple myeloma. |
| PubMedID- 21057704 | Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. |
| PubMedID- 22507814 | thrombosis in multiple myeloma (mm). |
Page: 1